Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07689617

Ultrasound-Guided Intermediate Cervical Plexus Block for Postoperative Analgesia in Vagus Nerve Stimulation Surgery

Sponsor: Firat University

View on ClinicalTrials.gov

Summary

This retrospective cohort study evaluated the medical records of adult patients who underwent vagus nerve stimulator (VNS) implantation under general anesthesia for drug-resistant epilepsy at Fırat University Hospital between January 2019 and December 2021. Patients who received a left-sided ultrasound-guided intermediate cervical plexus block (ICPB) with 10 mL of 0.25% bupivacaine as part of routine care were compared with patients who did not receive a regional block. The primary outcome was total intravenous morphine consumption during the first 24 postoperative hours. Secondary outcomes included intraoperative remifentanil consumption, postoperative pain intensity assessed using the Numeric Rating Scale (NRS) at rest and during movement, rescue morphine requirement, time to first rescue analgesia, length of hospital stay, and postoperative seizures within 24 hours, and block-related adverse events.

Official title: Intermediate Cervical Plexus Block as the Sole Regional Technique for Two-Site Vagus Nerve Stimulator Implantation: A Retrospective Cohort Study

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

OBSERVATIONAL

Enrollment

76

Start Date

2022-05-01

Completion Date

2022-09-30

Last Updated

2026-10-16

Healthy Volunteers

No

Interventions

PROCEDURE

Ultrasound-guided intermediate cervical plexus block

Ultrasound-guided intermediate cervical plexus block performed after induction of general anesthesia.

DRUG

Bupivacaine

10 mL of 0.25% bupivacaine administered during ultrasound-guided intermediate cervical plexus block.

Locations (1)

Fırat University Faculty of Medicine Hospital

Elâzığ, Elâzığ, Turkey (Türkiye)